CHICAGO — A medical device made by Novocure that creates electric fields in the lungs via wearable skin patches extended the survival of patients with lung cancer in a clinical trial, researchers ...

The life science industry recently gave folks diagnosed with pancreatic cancer the best news this group has received in a very long time. A new treatment option that significantly raises their chances ...

The first treatment of its kind for metastatic NSCLC, Optune Lua is approved for use concurrently with PD-1/PD-L1 inhibitors or docetaxel in adult patients with metastatic NSCLC who progressed on or ...

Young medical companies with new therapies often navigate a challenging path. That's true today for NovoCure (NASDAQ: NVCR), which makes a wearable device for treating cancer. The average investor ...

BAAR, Switzerland--(BUSINESS WIRE)--Novocure (NASDAQ: NVCR) today reported financial results for the quarter and full year ended December 31, 2024. Novocure is a global oncology company working to ...

Wearable Device to Treat Brain Cancer by Using Electrical Stimulation Medically reviewed by Brigid Dwyer, MD Optune is a ...

Optune Lua received a CE Mark for treating metastatic NSCLC, used with immune checkpoint inhibitors or docetaxel after progression on a platinum-based regimen. The phase 3 LUNAR trial showed ...

Electricity has formed the basis of many aspects of the modern world, from providing reliable sources of light to powering home appliances and computers. Now, researchers are studying how electricity ...

Novocure (NVCR 2.58%) and its international partner Zai Lab (ZLAB 2.60%) announced successful top-line results from the Panova-3 study on Dec. 2, 2024. In a nutshell, it showed that the company's ...